Eledon Pharmaceuticals, Inc. ELDN
- tegoprubart — Kidney Transplant Rejection Phase 2
- tegoprubart — Amyotrophic Lateral Sclerosis Phase 2
CD40L (1 companies · 2 programs)
Companies with an active program directed at CD40L.
Companies with an active program directed at CD40L.